The Department of Health and Social Care (DHSC) has announced that the government has granted multi-million-pound funding to phase 1 clinical trial platform to fast-track innovative treatments for coronavirus (COVID-19). This funding will allow the government to provide safer and effective treatments to the NHS 'rapidly through a more streamlined process'. The funding has been granted by the Medical Research Council and co-funded though the National Institute for Health Research. It will help increase the size the AGILE clinical trial platform and allow for global innovators to advance 'cutting-edge treatments for coronavirus through all three clinical trial phases in the UK'. The Health and Social Care Secretary, Matt Hancock, said: 'together, we can continue to ensure the UK is one of the best countries in the world for trialling and deploying the most groundbreaking medical advancements for both COVID-19 and for dangerous diseases in the future'.